In 2006 was created CTI Life Sciences Fund, which is appeared as VC. The fund was located in North America if to be more exact in Canada. The leading representative office of defined VC is situated in the Montru00e9al.
Among the most successful fund investment fields, there are Pharmaceutical, Medical Device. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Among the most popular portfolio startups of the fund, we may highlight SutroVax, Enobia Pharma, NeurAxon. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
Besides them, we counted 11 critical employees of this fund in our database.
Considering the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2018. The fund is constantly included in 2-6 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. This CTI Life Sciences Fund works on 1 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2017.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the CTI Life Sciences Fund, startups are often financed by Yaletown Partners, Polaris Partners, Flagship Pioneering. The meaningful sponsors for the fund in investment in the same round are Fonds de solidaritu00e9 FTQ, BDC Healthcare Venture, Yaletown Partners. In the next rounds fund is usually obtained by BDC Healthcare Venture, Yaletown Partners, Vertex Ventures HC.
Related Funds
Fund Name | Location |
BlueSky Capital | Canada, Ontario, Toronto |
Blumenstein/Thorne Information Partners | Illinois, Lake Forest, United States |
Claritas Health Ventures | Nashville, Tennessee, United States |
Core91 Fund | - |
Dadao Zongheng | Beijing, Beijing, China |
First IsraTech Fund | - |
Fuchun Communications Co | China, Foochow, Fujian |
Global Health Innovative Technology Fund | Karachi, Pakistan, Sindh |
Hearst Television Inc. | New York, New York, United States |
Inova Health System | Falls Church, United States, Virginia |
MAIFUND | Beijing, Beijing, China |
match2blue | Germany, Jena, Thuringia |
Oregon Life Sciences | Eugene, Oregon, United States |
Selta.es | Madrid, Móstoles, Spain |
Shijie Hesheng Management Consulting | China, Hubei, Wuhan |
Sun Life Financial | Canada, Ontario, Toronto |
Suxin Chuangtou | China, Jiangsu, Suzhou |
WeilaiGongchang | China, Guangdong, Shenzhen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Epitopea | 24 Oct 2024 | Cambridge, Cambridgeshire, United Kingdom | |||
Domain Therapeutics | $46M | 10 May 2022 | France, Grand Est, France | ||
Epitopea | $14M | 25 Apr 2022 | Cambridge, Cambridgeshire, United Kingdom | ||
Phenomic AI | $6M | 07 Oct 2020 | Ontario | ||
Find therapeutics | 01 Aug 2020 | Quebec | |||
Phenomic AI | $3M | 08 Jun 2020 | Old Toronto, Ontario, Canada | ||
Phenomic AI | $2M | 18 Jun 2018 | Old Toronto, Ontario, Canada | ||
Visterra | $23M | 05 Oct 2017 | Cambridge, Massachusetts, United States | ||
PreciThera | $28M | 27 Jul 2017 | Montreal, Quebec, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Epitopea | 24 Oct 2024 | Cambridge, Cambridgeshire, United Kingdom | |||
Domain Therapeutics | $46M | 10 May 2022 | France, Grand Est, France | ||
Epitopea | $14M | 25 Apr 2022 | Cambridge, Cambridgeshire, United Kingdom | ||
Phenomic AI | $6M | 07 Oct 2020 | Ontario | ||
Find therapeutics | 01 Aug 2020 | Quebec | |||
Phenomic AI | $3M | 08 Jun 2020 | Old Toronto, Ontario, Canada | ||
Phenomic AI | $2M | 18 Jun 2018 | Old Toronto, Ontario, Canada | ||
Visterra | $23M | 05 Oct 2017 | Cambridge, Massachusetts, United States | ||
PreciThera | $28M | 27 Jul 2017 | Montreal, Quebec, Canada |